Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases

Go back to Resources

Visual Acuity as an Outcome Measure in Clinical Trials of Retinal Diseases

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Use of rhGH in Children with Chronic Kidney Disease: Lessons from NAPRTCS

Go back to Resources

Use of rhGH in Children with Chronic Kidney Disease: Lessons from NAPRTCS

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Role of Practice Based Research Networks (PBRN) in the Spectrum of Clinical Trials

Go back to Resources

The Role of Practice Based Research Networks (PBRN) in the Spectrum of Clinical Trials

Authors:

Go back to Resources

The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 20

Go back to Resources

The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 20

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22

Go back to Resources

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake with Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

The NCI Pediatric Central Institutional Review Board (PedCIRB) Initiative: Progress and Impact

Go back to Resources

The NCI Pediatric Central Institutional Review Board (PedCIRB) Initiative: Progress and Impact

Authors:

Secondary:

Volume:

Publisher:

Abstract:

Go back to Resources

The National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC)

Go back to Resources

The National Institute of Neurological Disorders and Stroke (NINDS) Clinical Research Collaboration (CRC)

Authors:

Secondary:

Location:

Go back to Resources

Motor Function and Human Immunodeficiency Virus-Associated Cognitive Impairment in a Highly Active Antiretroviral Therapy-Era Cohort

Go back to Resources

Motor Function and Human Immunodeficiency Virus-Associated Cognitive Impairment in a Highly Active Antiretroviral Therapy-Era Cohort

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration

Go back to Resources

Late Outgrowth Endothelial Progenitor Cells in Patients with Age-Related Macular Degeneration

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids

Go back to Resources

Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • Current page 174
  • Page 175
  • Page 176
  • Page 177
  • Page 178
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification